Abbott Laboratories (ABT) Is A Key Player In Closed Loop Neurostimulation

Abbott Laboratories (NYSE:ABT) has been identified as a leading group advancing closed-loop neurostimulation in bioelectronic medicine devices. The company is highlighted for closed-loop neurostimulation systems that interact with neural signals to modulate treatment in real time. This focus on bioelectronic medicine complements Abbott's existing work in cardiac and diabetes devices targeting chronic and neurological conditions. The recognition of Abbott's closed-loop neurostimulation push...